Compound: meglumine
SMILES: O[C@@H]([C@H](O)[C@@H](O)CNC)[C@H](O)CO
InChIKey: MBBZMMPHUWSWHV-BDVNFPICSA-N
Synonyms: meglumine, N-Methyl-D-glucamine, 6284-40-8, Methylglucamine, N-Methylsorbitylamine, D-Glucitol, 1-deoxy-1-(methylamino)-, Megluminum, 1-Deoxy-1-methylaminosorbitol, N-Methyl-D(-)-glucamine, d(-)-n-methylglucamine, 1-deoxy-1-methylamino-d-glucitol, 6HG8UB2MUY, D-(-)-N-Methylglucamine, NSC-7391, NSC-52907, CHEBI:59732, NSC52907, NSC7391, antimoniate de mAglumine, RefChem:389110, GlyTouCan:G20950LN, P01CB01, G20950LN, 228-506-9, N-Methylglucamine, Meglumin, 1-Deoxy-1-(methylamino)-D-glucitol, Meglumina, (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol, (2R,3R,4R,5S)-6-(Methylamino)hexane-1,2,3,4,5-pentaol, C7H17NO5, Sorbitol, 1-deoxy-1-methylamino-, MFCD00004707, DTXSID0023244, NSC 7391, NSC 52907, Megluminum [INN-Latin], Meglumina [INN-Spanish], Glucitol, 1-deoxy-1-(methylamino)-, D-, DTXCID503244, UNII-6HG8UB2MUY, EINECS 228-506-9, Meglumine CRS, Meglumine [USP:INN:BAN:JAN], 1-Methylamino-1-deoxy-D-glucitol, N-methyl-glucamine, N-Methyl glucamine, NCGC00166125-01, CAS-6284-40-8, n-methyl-d glucamine, Meglumine (Standard), Meglumine (Excipient), MEGLUMINE [INN], MEGLUMINE [JAN], Fosaprepitant Impurity H, MEGLUMINE [II], MEGLUMINE [VANDF], MEGLUMINE [MART.], EC 228-506-9, MEGLUMINE [USP-RS], MEGLUMINE [WHO-DD], MEGLUMINE [WHO-IP], SCHEMBL2193, BIDD:GT0676, Meglumine (JP17/USP/INN), N-METHYLGLUCAMINE [MI], orb1310549, SCHEMBL3530506, MEGLUMINE [ORANGE BOOK], CHEMBL1200570, MEGLUMINE [EP MONOGRAPH], HY-B0342A, HY-B0342R, (2R,3R,4R,5S)-6-Methylaminohexane-1,2,3,4,5-pentaol, MEGLUMINE [USP MONOGRAPH], MEGLUMINUM [WHO-IP LATIN], 1-deoxy-1-(methylamino)-glucitol, HMS2089B05, HMS3714B10, Pharmakon1600-01300029, HY-B0342, Tox21_112330, Tox21_302037, EBC-26175, NSC759607, s1974, AKOS005167162, AKOS015850890, N-methyl-1-amino-1-deoxy-D-glucitol, Tox21_112330_1, AC-4692, CCG-220884, MM07027, NSC-759607, RP10191, Meglumine 100 microg/mL in Acetonitrile, NCGC00166125-02, NCGC00255365-01, AC-17087, AS-12002, SBI-0206683.P002, Meglumine, meets USP testing specifications, M0227, SW199350-2, D01796, AB00430469-03, AB00430469_05, EN300-2394659, F050328, Q288875, SR-05000001446, N-Methyl-D-Glucamine(Discontinued,SeeCPTD788384), N-Methyl-D-glucamine, 99.0-100.5% (titration), SR-05000001446-1, BRD-K28595280-001-01-1, BRD-K28595280-001-03-7, BRD-K28595280-001-04-5, BRD-K28595280-001-05-2, N-Methyl-D-glucamine, Vetec(TM) reagent grade, 99%, N-Methyl-D-glucamine, ReagentPlus(R), >=99.0% (T), Z1255485274, (2R,3R,4R,5S)-6-methylamino-hexane-1,2,3,4,5-pentaol, Meglumine, United States Pharmacopeia (USP) Reference Standard, N-methyl-(2 (S),3 (R),4 (R),5 (R),6-pentahydroxy-hexyl)-amine, Meglumine, Pharmaceutical Secondary Standard; Certified Reference Material, N-Methyl-D-glucamine, European Pharmacopoeia (EP) Reference Standard, Surfactant, Contrast agent, Antiemetic, Antial ergic, Anti kala-azar, Anticancer, Anti-inflammatory, Anti-infectives
Theoretical properties:
molecular_formula: C7H17NO5
molecular_weight: 195.21 g/mol
exact_mass: 195.11067264 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 6
hydrogen_bond_acceptor_count: 6
rotatable_bond_count: 6
heavy_atom_count: 13
topological_polar_surface_area: 113 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
pubchem: N-methylglucamine is a hexosamine that is D-glucitol in which the hydroxy group at position 1 is substituted by the nitrogen of a methylamino group. A crystalline base, it is used in preparing salts of certain acids for use as diagnostic radiopaque media, while its antimonate is used as an antiprotozoal in the treatment of leishmaniasis. It is a hexosamine and a secondary amino compound.
chebi: A  hexosamine that is <small>D</small>-glucitol in which the hydroxy group at position 1 is substituted by the nitrogen of a methylamino group. A crystalline base, it is used in preparing salts of certain acids for use as diagnostic radiopaque media, while its antimonate is used as an antiprotozoal in the treatment of leishmaniasis.
chembl: MEGLUMINE is a small molecule listed in the ChEMBL database and has reached clinical trial phase 4.0.
wikipedia: Meglumine is a sugar alcohol derived from glucose that contains an amino group modification.  It is often used as an excipient in pharmaceuticals and in conjunction with iodinated compounds in contrast media such as diatrizoate meglumine,  iothalamate meglumine, and iodipamide meglumine.